Thodupuzha Medigen Private Limited - Due diligence report

A 360° intelligence report on Thodupuzha Medigen Private Limited: trust score, financial health, credit view, compliance, directors, growth …

2018-08-16 Cochin, Kerala Active Unlisted
Share
Connect MCP
TM Thodupuzha Medigen Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Thodupuzha Medigen Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
83/100
Trust Score
Low Risk

Thodupuzha Medigen Private Limited is assessed as Low Risk with a Trust Score of 83/100. Thodupuzha Medigen Private Limited is an active private limited indian non-government company incorporated in 2018, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 09 Aug 2026 from the latest processed filings. Thodupuzha Medigen Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
83/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 1 satisfied (30.00 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
City Union Bank Limited1 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
RAHUL MAMMAN ABRAHAM 01234567 Director 01/04/2018 6 yrs Approved
MAMMAN ABRAHAM 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
M.p.c. Pharma Private Limited
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
M.p.c. Pharma Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 80
Growth signals & trust indicators
Profit expanded 38% year-on-year.
Asset base grew 1.42 - capacity expansion.
Net margin improved to 2.1x.
Operating for 7 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 24% in a year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence84/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment69/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view75/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 8 events
16 May 2025
Director ceased
MIRIAM VERGHESE
30 Sep 2024
Last AGM held
Annual general meeting
03 Apr 2024
Charge satisfied
City Union Bank Limited
31 Mar 2024
Latest balance sheet
Filed with ROC
28 Feb 2022
Charge created
City Union Bank Limited - 30.00 Lakh
16 Aug 2018
Incorporated
Registered with Roc Ernakulam
Director appointed
RAHUL MAMMAN ABRAHAM (Director)
Director appointed
MAMMAN ABRAHAM (Director)
10

Key Observations

Auto-generated from the data above
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Pahadimata Cloth Private Limited U74900WB2009PTC139045 Kolkata, West Bengal, India
New Era Woollen Mills Pvt Ltd U17223WB1971PTC027955 Kolkata, West Bengal, India
Bareilly Wooden Crafts Private Limited U20296UP2013PTC056108 Bareilly, Uttar Pradesh, India
Grace Home Style Trade Private Limited U52339KL2014PTC036604 Cochin, Kerala, India
Woodman Trading Company Private Limited U20101GJ2002PTC040392 Gandhidham -Kutch, Gujarat, India
Sardar Fashion Private Limited U74120UP2011PTC044098 Varanasi, Uttar Pradesh, India
Brikhot Home Private Limited U51101MH2010PTC199978 Mumbai, Maharashtra, India
Circles Safety & Certification Private Limited U74999TN2017PTC114426 Chennai, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Thodupuzha Medigen Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Thodupuzha Medigen Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Thodupuzha Medigen Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 83/100, distress signals and MSME payment-delay disclosures - know whether Thodupuzha Medigen Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Thodupuzha Medigen Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Thodupuzha Medigen Private Limited an active company?

Thodupuzha Medigen Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Thodupuzha Medigen Private Limited financially healthy?

Thodupuzha Medigen Private Limited has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Thodupuzha Medigen Private Limited?

Its overall Trust Score is 83/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Thodupuzha Medigen Private Limited?

The ultimate holding entity is M.p.c. Pharma Private Limited. 2 active director(s) are on record.

Does Thodupuzha Medigen Private Limited have loans or charges against its assets?

No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Thodupuzha Medigen Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Thodupuzha Medigen Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.